Databricks launches AiChemy multi-agent AI for drug discovery
Briefly

Databricks launches AiChemy multi-agent AI for drug discovery
"AiChemy brings these data access, orchestration, and analysis in a single, governed environment, which Databricks says will help researchers in pharma companies surface relevant insights from disparate datasets without losing context."
"The system combines these agents and skills with external data sources such as OpenTargets, PubMed, and PubChem, accessed via MCP, allowing agents to retrieve and reason over both proprietary and public scientific data."
AiChemy combines multiple skills for querying scientific literature, retrieving chemical data, and performing similarity searches. It utilizes external data sources like OpenTargets, PubMed, and PubChem through MCP. This integration allows agents to access and analyze both proprietary and public scientific data. The system aims to provide a governed environment that helps researchers in pharmaceutical companies extract relevant insights from diverse datasets, thereby accelerating processes such as target identification and candidate evaluation.
Read at InfoWorld
Unable to calculate read time
[
|
]